Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/25/2011 | EP2325339A2 Methods and compositions for generation of germline human antibody genes |
05/25/2011 | EP2325337A1 RNA aptamers and methods for identifying the same |
05/25/2011 | EP2325336A1 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
05/25/2011 | EP2325335A2 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
05/25/2011 | EP2325333A1 MicrorRNAs and uses thereof |
05/25/2011 | EP2325332A1 Use of crispr associated genes (CAS) |
05/25/2011 | EP2325331A1 MicroRNAs and Uses Thereof |
05/25/2011 | EP2325330A1 METHOD FOR SIMULTANEOUS DETECTION OF VIROIDS PSTVd AND TCDVd |
05/25/2011 | EP2325325A1 Methods for the reduction of stutter in microsatellite amplification |
05/25/2011 | EP2325324A1 Genetically purified gellan gum |
05/25/2011 | EP2325322A1 Retroviral vector particles and methods for their generation and use |
05/25/2011 | EP2325321A1 A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector |
05/25/2011 | EP2325320A1 Directed complementation |
05/25/2011 | EP2325319A2 Product and process for transformation of Thraustochytriales microorganisms |
05/25/2011 | EP2325318A1 Protease variants |
05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
05/25/2011 | EP2325316A1 Novel hemopoietin receptor protein, nr10 |
05/25/2011 | EP2325315A1 Compositions and methods for inhibiting expression of huntingtin gene |
05/25/2011 | EP2325314A2 Targeting opposite strand replication intermediates of single-stranded viruses by RNAI |
05/25/2011 | EP2325313A2 pRNA chimera |
05/25/2011 | EP2325312A1 Method for selective enrichment and isolation of microbial and optional additionally of viral nucleic acids |
05/25/2011 | EP2325311A1 Novel phage display vector |
05/25/2011 | EP2325310A1 Method for obtaining purkinje progenitor cell by using neph3(65b13) and e-cadherin |
05/25/2011 | EP2325309A1 Method for detection of paecilomyces variotii |
05/25/2011 | EP2325308A2 Methods and materials for making and using transgenic dicamba-degrading organisms |
05/25/2011 | EP2325307A1 I-crel meganuclease variants with modified specificity, method of preparation and uses thereof |
05/25/2011 | EP2325303A2 Thermostable reverse transcriptases and uses thereof |
05/25/2011 | EP2325302A1 Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (FGE) |
05/25/2011 | EP2325301A1 Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (FGE) |
05/25/2011 | EP2325300A1 Desaturase genes and uses thereof |
05/25/2011 | EP2325299A2 Methods for generating high titer helper-free preparations of recombinant AAV vectors |
05/25/2011 | EP2325208A1 Polyubiquitin antibodies |
05/25/2011 | EP2325204A2 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
05/25/2011 | EP2325203A2 Cadherin materials and methods |
05/25/2011 | EP2325202A1 Uses of interferons with altered spatial structure |
05/25/2011 | EP2325198A1 Compositions and methods for the therapeutic use of an atonal-associated sequence |
05/25/2011 | EP2325197A2 Expression control elements from the Lemnaceae family |
05/25/2011 | EP2325196A1 Replikin peptides and uses thereof |
05/25/2011 | EP2325193A2 Methods and compositions for therapeutic use of RNA interference |
05/25/2011 | EP2324856A1 Single-stranded oligodeoxynucleotide mutational vectors |
05/25/2011 | EP2324847A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors |
05/25/2011 | EP2324844A2 April receptor (BCMA) and uses thereof |
05/25/2011 | EP2324842A1 Immunity-inducing agent |
05/25/2011 | EP2324839A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
05/25/2011 | EP2324834A2 Methods of Increasing Endogenous Erythropoietin (EPO) |
05/25/2011 | EP2324704A2 Method and apparatus for substantially isolating plant tissues |
05/25/2011 | EP2324703A1 Method for improving water use efficiency in plants |
05/25/2011 | EP2324353A1 Selectively functionized transducer microarray |
05/25/2011 | EP2324131A1 Method for small rna isolation |
05/25/2011 | EP2324122A1 Production of cellulase enzymes in plant hosts using transient agroinfiltration |
05/25/2011 | EP2324121A1 Improved vectors and yeast strains for protein production: ca2+ atpase overexpression |
05/25/2011 | EP2324120A2 Manipulation of snf1 protein kinase activity for altered oil content in oleaginous organisms |
05/25/2011 | EP2324117A2 Increasing cell wall deposition and biomass in plants |
05/25/2011 | EP2324116A1 Nucleotide sequence encoding an alcohol dehydrogenase from artemisia annua and uses thereof |
05/25/2011 | EP2324115A1 Method for isolating and purifying nucleic acids |
05/25/2011 | EP2324114A2 Method for isolating and purifying nucleic acids |
05/25/2011 | EP2324062A1 Chimeric respiratory syncytial virus polypeptide antigens |
05/25/2011 | EP2324061A1 Multispecific antibodies |
05/25/2011 | EP2324057A1 Minigene comprising htpa signal peptide, t-cell epitopes, e. coli ltb and furin sensitive linkers |
05/25/2011 | EP2324050A1 Vaccine compositions |
05/25/2011 | EP2324045A2 Photo-crosslinked nucleic acid hydrogels |
05/25/2011 | EP2323685A2 Agonists of nr2f6 for immunosuppression |
05/25/2011 | EP2323677A1 Micro-rna-based compositions and methods for the diagnosis, prognosis and treatment of multiple myeloma |
05/25/2011 | EP2323475A1 High fructan cereal plants |
05/25/2011 | EP2082750B1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
05/25/2011 | EP2003969B1 Mature dendritic cell compositions and methods for culturing same |
05/25/2011 | EP1984502B1 Nucleic acid |
05/25/2011 | EP1973937B1 Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof |
05/25/2011 | EP1945270B1 Compositions and methods for inhibiting expression of factor v leiden mutant gene |
05/25/2011 | EP1934351B1 Abiotic stress tolerant gene from avicennia marina encoding a protein |
05/25/2011 | EP1766012B1 Antisense antibacterial method and compound |
05/25/2011 | EP1730287B1 Inducible promoters |
05/25/2011 | EP1664118B1 Tlr2 antagonistic antibody and use thereof |
05/25/2011 | EP1629095B1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
05/25/2011 | EP1499731B1 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
05/25/2011 | EP1412505B1 Dna sequences for regulating transcription |
05/25/2011 | EP1390548B1 Cells for detection of enteroviruses |
05/25/2011 | EP1366077B1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
05/25/2011 | EP1358341B1 Methods for generating resistance against cgmmv in plants |
05/25/2011 | EP1350431B1 Method of selecting antimicrobial agent and method of using the same |
05/25/2011 | EP1345959B1 Membrane scaffold proteins |
05/25/2011 | EP1183330B1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
05/25/2011 | EP1172437B1 Novel desensitized aspartokinase |
05/25/2011 | EP1055736B1 Method for dna sequencing |
05/25/2011 | EP1051522B1 Method for quantitatively analyzing tumor cells in a body fluid and test kits suited therefor |
05/25/2011 | EP0959896B1 Method of producing secreted truncated variants of human thyrotropin receptor |
05/25/2011 | EP0948610B1 Subtilase variants and compositions |
05/25/2011 | CN1993039B Method for making plants having improved growth characteristics |
05/25/2011 | CN1912127B Colibacillus expression carrier and its application |
05/25/2011 | CN1871347B Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in |
05/25/2011 | CN1772897B Cell factor with several functions |
05/25/2011 | CN1662652B Randomised DNA libraries and double-stranded RNA libraries, use and method of production thereof |
05/25/2011 | CN1531594B Novel glyphosate N-acetyltransferase (GAT) genes |
05/25/2011 | CN102076864A Recombinant cell producing 2-hydroxyisobutyric acid |
05/25/2011 | CN102076863A Process for producing organic acid |
05/25/2011 | CN102076860A Method of producing yeast biomass |
05/25/2011 | CN102076858A Novel bacillus thuringiensis gene with lepidopteran activity |
05/25/2011 | CN102076857A Methods and means to modify fiber strength in fiber-producing plants |
05/25/2011 | CN102076856A Compositions and methods for enhancing amino acid levels in plants |